Back
Cadrenal Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
64
CVKD
Cadrenal Therapeutics
Last Price:
0.49
Seasonality Move:
-40.76%
Sell
19
NBY
NovaBay Pharmaceuticals
Last Price:
2.65
Seasonality Move:
-14.14%
Buy
64
Cadrenal Therapeutics (CVKD)
is a Buy
Is Cadrenal Therapeutics a Buy, Sell or Hold?
- The current Cadrenal Therapeutics [CVKD] share price is $0.48. The Score for CVKD is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- CVKD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $2.51. The Score for NBY is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CVKD Stock Price Chart
What is Cadrenal Therapeutics's stock price today?
-
The Cadrenal Therapeutics share price today is $0.48
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CVKD is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $2.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight buying pressure.
CVKD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 53.79 | Buy |
| Chaikin Money Flow: | 26319 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.42 - 0.48) | Buy |
| Bollinger Bands (100): | (0.34 - 0.96) | Sell |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 39.68 | Sell |
| Chaikin Money Flow: | 71816 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.63 - 4.69) | Sell |
| Bollinger Bands (100): | (3.06 - 5.28) | Sell |
CVKD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.47 | Buy |
| 20-day SMA: | 0.45 | Buy |
| 50-day SMA: | 0.45 | Buy |
| 200-day SMA: | 0.63 | Sell |
| 8-day EMA: | 0.47 | Buy |
| 20-day EMA: | 0.46 | Buy |
| 50-day EMA: | 0.49 | Sell |
| 200-day EMA: | 0.75 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.75 | Sell |
| 20-day SMA: | 3.75 | Sell |
| 50-day SMA: | 3.33 | Sell |
| 200-day SMA: | 8.15 | Sell |
| 8-day EMA: | 2.84 | Sell |
| 20-day EMA: | 3.25 | Sell |
| 50-day EMA: | 3.63 | Sell |
| 200-day EMA: | 15.15 | Sell |
Cadrenal Therapeutics Earnings Growth & CVKD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.04 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.48 per share, an increase next quarter of $0.35 per share, an increase this year of $74.90 per share, and an increase next year of $5.60 per share.
Cadrenal Therapeutics Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||